Versant Venture Management

Versant Ventures is a leading healthcare venture capital firm that specializes in investing in and building breakthrough biopharmaceutical companies. Managing over $4 billion in assets, the firm operates across North America and Europe, focusing on high-impact therapeutic innovations. Versant is well-known for its 'Discovery Engine' model, where it internalizes drug discovery through dedicated laboratories like Ridgeline and Inception Sciences to launch new startups. Their investment portfolio spans diverse modalities including small molecules, biologics, and cell and gene therapies. The firm has a strong track record of successful exits, with many portfolio companies being acquired by major pharmaceutical firms or reaching the public markets via IPO. Versant's team comprises experienced investment professionals and scientists who provide deep operational and strategic support to their portfolio.